1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Ivacaftor therapy post myocardial infarction augments systemic inflammation and evokes contrasting effects with respect to tissue inflammation in brain and lung
(
- Contribution to journal › Article
- 2022
-
Mark
Therapeutic CFTR Correction Normalizes Systemic and Lung-Specific S1P Level Alterations Associated with Heart Failure
(
- Contribution to journal › Article
-
Mark
Restoring myocardial infarction-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator
(
- Contribution to journal › Article
-
Mark
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
(
- Contribution to journal › Article
- 2020
-
Mark
Targeting cerebrovascular sphingosine‐1‐phosphate signaling to treat heart failure‐induced brain dysfunction
(
- Contribution to journal › Published meeting abstract
-
Mark
Improving cerebrovascular function to increase neuronal recovery in neurodegeneration associated to cardiovascular disease
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Targeting sphingosine-1-phosphate signaling to treat heart failure-induced memory deficits
(
- Contribution to journal › Published meeting abstract
-
Mark
CFTR Therapeutics Normalize Cerebral Perfusion Deficits in Mouse Models of Heart Failure and Subarachnoid Hemorrhage
(
- Contribution to journal › Article